FDA Inspection
Saptalis Pharmaceuticals LLCSaptalis Pharmaceuticals LLC – FDA Inspection, Sep 9, 2025
Record Details
This FDA Inspection record concerns Saptalis Pharmaceuticals LLC, with an inspection on September 9, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a4f7cdc9-dc8b-4a3f-b40a-4f847e018bd2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1283250
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Saptalis Pharmaceuticals LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2026 | Not classified | New York District Office | Drug Quality Assurance |
| March 17, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2018 | Not classified | New York District Office | |
| March 28, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Saptalis Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.